Nutex Health, Inc.

85
Strong Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67079U1088
USD
156.79
27.02 (20.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
479.00
247.00
219.00
331.00
1.00
1.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
479.00
247.00
219.00
331.00
1.00
1.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
19.00
16.00
12.00
6.00
0.00
0.00
General and Administration Expenses
58.00
36.00
18.00
5.00
3.00
4.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
342.00
248.00
223.00
157.00
5.00
6.00
Operating Profit (PBDIT) excl Other Income
137.00
-1.00
-4.00
173.00
-3.00
-4.00
Other Income
0.00
0.00
0.00
5.00
1.00
0.00
Operating Profit (PBDIT)
157.00
15.00
8.00
187.00
-1.00
-4.00
Interest
19.00
16.00
12.00
6.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
18.00
17.00
13.00
7.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
109.00
-48.00
-419.00
169.00
-5.00
-7.00
Provision for Tax
14.00
-5.00
13.00
0.00
0.00
0.00
Profit After Tax
52.00
-45.00
-424.00
132.00
-5.00
-7.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
9.71
-10.39
-100.36
33.55
-175.80
-294.06
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 93.80% vs 12.93% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 10,762.29% vs 71.79% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 22.15% vs 30.64% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 213.96% vs 89.22% in Dec 2023

Compare Profit and Loss Results of Nutex Health, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
479.00
18.00
461.00
2,561.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
479.00
18.00
461.00
2,561.11%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
19.00
0.00
19.00
0%
General and Administration Expenses
58.00
8.00
50.00
625.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
342.00
22.00
320.00
1,454.55%
Operating Profit (PBDIT) excl Other Income
137.00
-4.00
141.00
3,525.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
157.00
-2.00
159.00
7,950.00%
Interest
19.00
0.00
19.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
18.00
1.00
17.00
1,700.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
109.00
-4.00
113.00
2,825.00%
Provision for Tax
14.00
0.00
14.00
0%
Profit After Tax
52.00
-4.00
56.00
1,400.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.7106
-2.9273
12.64
431.73%
Profit And Loss - Net Sales
Net Sales 479.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 93.80% vs 12.93% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 137.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10,762.29% vs 71.79% in Dec 2023

Profit And Loss - Interest
Interest 19.93 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.15% vs 30.64% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 52.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 213.96% vs 89.22% in Dec 2023